P&G furthers Olympics support
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble will sponsor the Team USA Family Home, a "home-away-from-home" for Olympic Athletes at the 2010 Winter Games in Vancouver. The home will provide athletes and their families "a place to come together in an inviting and welcoming environment," firm says. Amenities include pampering at the P&G Beauty and Grooming Salon and Spa with "quick refreshes to complete makeovers" by Pantene, Cover Girl, Olay, Venus and Secret and a Crest/Oral B Smile Center. On Jan. 7, P&G announced additional sponsorship deals with Olympians. Athletes affiliated with P&G's Crest brand include pairs skaters Rockne Brubaker and Keauna McLaughlin, speed skater J.R. Celski, hockey player Julie Chu, curler Nicole Joraanstad, skier Julia Mancuso and snowboarder Seth Wescott. Figure skater Sasha Cohen is affiliated with firm's Pepto brand. P&G previously announced marketing collaborations with Olympic athletes Allison Baver, Tanith Belbin, Vonetta Flowers, Lindsey Jacobellis, Apolo Ohno and Lindsey Vonn (1"The Rose Sheet" Oct. 5, 2009)
You may also be interested in...
P&G and Team USA align
Procter & Gamble announces marketing collaborations with Team USA athletes extending through the 2010 Olympic Winter Games in Vancouver. Speed skater Allison Baver, ice dancer Tanith Belbin, bobsledder Vonetta Flowers and alpine skier Lindsey Vonn are linked with beauty brands Cover Girl, Olay, Olay Quench, Pantene, Secret and Venus. Speed skater Apolo Ohno and snowboarder Lindsey Jacobellis align with Vicks. "Partnering with these world-class athletes further accentuates our commitment to Team USA and P&G's long tradition of helping people achieve their personal best each and every day," says Kirk Perry, P&G's VP for North America. "Each one of these athletes has a unique personality that fits within our brands' equities, and we are confident they will resonante with our target consumers." P&G will sponsor Team USA in the 2012 Olympic Games as well (1"The Rose Sheet" Sept. 7, 2009)
UK Medtech Strategy Sets Out Schedule Of Milestones To FY 2026
Fourteen months on from the release of its inaugural medtech strategy, the UK MedTech Directorate has laid firm foundations and reports progress on initiatives aimed at improving technology adoption. A schedule of ambitious future timelines has also been published.
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.